Compare H1B visa sponsorship data between Goldman Sachs and Invagen Pharmaceuticals. See how they stack up on salary, approval rates, and more.
Key Statistics Comparison
Total H1B Filings
+3674%
14,154
Goldman Sachs
375
Invagen Pharmaceuticals
Median Salary
+25.8%
$113,200
Goldman Sachs
$90,000
Invagen Pharmaceuticals
Approval Rate
99.0%
Goldman Sachs
100.0%
Invagen Pharmaceuticals
Years Sponsoring
18
Goldman Sachs
18
Invagen Pharmaceuticals
Historical Trends
H1B Filings Over Time
Goldman Sachs
Invagen Pharmaceuticals
Median Salary Trend
Goldman Sachs
Invagen Pharmaceuticals
Where & What They Hire
Top H1B Job Categories
Goldman Sachs
Software Developers 131 filings
Financial and Investment Analysts 83 filings
Financial Quantitative Analysts 73 filings
Financial Risk Specialists 72 filings
Business Intelligence Analysts 63 filings
Invagen Pharmaceuticals
Chemists 6 filings
Regulatory Affairs Specialists 4 filings
Document Management Specialists 1 filings
Industrial Engineers 1 filings
Mechanical Engineers 1 filings
Top H1B Work Locations
Goldman Sachs
Dallas, TX 249 filings
Salt Lake City, UT 209 filings
New York, NY 169 filings
Jersey City, NJ 14 filings
New York, NY 12 filings
Invagen Pharmaceuticals
Central Lslip, NY 8 filings
Fall River, MA 2 filings
Falls River, MA 2 filings
Central Islip, NY 1 filings
Fall River, MA 1 filings
Year-by-Year Breakdown
| Year | Goldman Sachs | Invagen Pharmaceuticals | ||||
|---|---|---|---|---|---|---|
| Filings | Salary | Approval | Filings | Salary | Approval | |
| FY2025 | 731 | $113,200 | 99.0% | 15 | $90,000 | 100.0% |
| FY2024 | 310 | $145,000 | 100.0% | 5 | $90,000 | 100.0% |
| FY2023 | 186 | $150,000 | 100.0% | 2 | $75,000 | 100.0% |
| FY2022 | 306 | $149,000 | 100.0% | 8 | $95,592 | 100.0% |
| FY2021 | 527 | $125,000 | 100.0% | 7 | $85,000 | 100.0% |
| FY2020 | 249 | $138,000 | 100.0% | 2 | $93,768 | 100.0% |
| FY2019 | 1,726 | $115,000 | 98.7% | 25 | $72,792 | 100.0% |
| FY2018 | 1,779 | $110,000 | 98.7% | 29 | $55,000 | 100.0% |
| FY2017 | 1,085 | $103,600 | 99.0% | 12 | $55,825 | 100.0% |
| FY2016 | 1,086 | $105,050 | 98.2% | 20 | $65,011 | 100.0% |
Showing most recent 10 years of 18 total
Frequently Asked Questions
- Which company pays higher H1B salaries, Goldman Sachs or Invagen Pharmaceuticals?
- Goldman Sachs pays higher H1B salaries with a median of $113,200 compared to Invagen Pharmaceuticals's $90,000.
- Which company sponsors more H1B visas, Goldman Sachs or Invagen Pharmaceuticals?
- Goldman Sachs has sponsored more H1B visas with 14,154 total filings compared to Invagen Pharmaceuticals's 375.
- How do Goldman Sachs and Invagen Pharmaceuticals H1B approval rates compare?
- Goldman Sachs has a 99.0% H1B approval rate while Invagen Pharmaceuticals has 100.0%. Invagen Pharmaceuticals has a higher approval rate.